Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Zealand Pharma A/S

Recent news which mentions Zealand Pharma A/S

Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
Tags Biotech and Pharmaceuticals Europe News Biotechnology
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Biotech and Pharmaceuticals Altimmune Inc Novo Nordisk A/S
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Breaking News: Markets Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Health & Science Viking Therapeutics Inc Gilead Sciences Inc
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Novo Nordisk A/S Eli Lilly and Co Breaking News: Markets
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Eli Lilly and Co Investing U/S/ Markets
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Business Health care industry Zealand Pharma A/S
From CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
Tags Madrigal Pharmaceuticals Inc Viking Therapeutics Inc Health & Science
From CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
Tags Biotech and Pharmaceuticals UnitedHealth Group Inc Zealand Pharma A/S
From CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
Tags Pharmaceuticals Novo Nordisk A/S Zealand Pharma A/S
From CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
Tags Viking Therapeutics Inc Pfizer Inc US: News
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.